IMF Videos Search Content For Care Partner (351) Patient (347) Healthcare Provider (213) Healthcare Professional (210) Series - Any - About the IMF (2) ASCO/EHA (71) ASH (102) Ask Dr. Durie (149) Black Swan Research Initiative (7) Community Workshops (5) Emerging Therapies (18) Facebook Live (21) Health Equity (14) IMF History (3) IMWG (12) Inspirational (15) Living Well with Myeloma (33) Myeloma in a Minute (22) Myeloma Made Simple (15) Myeloma University (12) NLB Webcasts (1) Patient & Family Webinar (11) Q&A (21) Recent News and Developments (5) Treatments (3) Trending Searches in Myeloma (4) Topics Clinical Trials (185) Financial Considerations (15) Frontline Therapy (83) Health Equity (34) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (69) Lifestyle (47) Mental & Emotional Health (28) Myeloma 101 (56) Myeloma in the News (7) Public Policy & Advocacy (17) Q&A's (42) Recorded Seminars & Workshops (15) Recorded Webinars (24) Relapse/Refractory Myeloma (136) Research Updates (193) Symptom Management (114) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (147) High-Risk Myeloma (96) High-risk Smoldering Myeloma (70) Late Relapse (4–6 Lines of Therapy) (158) MGUS (85) Newly Diagnosed (Pre-Treatment or First Treatment) (158) Smoldering Myeloma (109) Types of Therapy Immunomodulatory drugs (IMiDs) (94) Immunotherapies (CAR T; BiTE, etc.) (161) Monoclonal antibodies (78) Proteasome inhibitors (66) Stem cell transplant (84) Steroids (63) Supportive Care (152) Year Published 2026 (44) 2025 (107) 2024 (93) 2023 (92) 2022 (36) 2021 (31) 2020 (13) 2019 (36) 2018 (21) 2017 (30) 2016 (24) 2015 (30) Trusted Voices Dr. Brian GM Durie (144) Dr. Joseph Mikhael (103) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (29) Dr. María-Victoria Mateos (7) Donna Catamero, ANP-BC, OCN, CCRC (5) Dr. Saad Usmani (4) Dr. Sigurður Kristinsson (4) Dr. Urvi A. Shah (4) Dr. Shaji Kumar (3) Dr. S. Vincent Rajkumar (1) Dr. Sagar Lonial (1) Dr. Tom Martin (1) Heather Cooper Ortner (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance Elranatamab: Extended Follow-up & Biweekly Admin for RRMM | MagnetisMM-3 Study June 13, 2023 ASCO/EHA Myeloma Made Simple: Shared Decision Making Made Simple May 31, 2023 Myeloma Made Simple What is MGUS? May 11, 2023 Ask Dr. Durie What is minimal residual disease (MRD)? May 4, 2023 Ask Dr. Durie What are the differences between CAR T-cell therapy and bispecific antibodies? April 13, 2023 Ask Dr. Durie Myeloma ACTION Month: Special Q&A with Beth Faiman March 31, 2023 Facebook Live Living Well with Myeloma Webinar - New Drugs in Myeloma – What, How and When? What Patients and Care Partners Need to Know March 30, 2023 Living Well with Myeloma What does it mean to have functional high-risk multiple myeloma? March 30, 2023 Ask Dr. Durie Robin and Michael Tuohy's Myeloma Journey in BloodCounts Story Corps March 24, 2023 Inspirational Myeloma ACTION Month: Special Q&A with Dr. Joseph Mikhael March 22, 2023 Facebook Live Elranatamab in Combination with Daratumumab for Patients with Relapsed Refractory Multiple Myeloma: Phase 3 MagnetisMM-5 February 10, 2023 ASH The International Myeloma Foundation's M-Power Project February 8, 2023 Health Equity Load More
